A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients
- 30 June 2007
- journal article
- clinical trial
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 41 (3-4) , 351-359
- https://doi.org/10.1016/j.jpsychires.2005.07.009
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: A meta-analysisThe British Journal of Psychiatry, 2002
- Severity of Depression and Response to Antidepressants and Placebo: An Analysis of the Food and Drug Administration DatabaseJournal of Clinical Psychopharmacology, 2002
- Symptom Reduction and Suicide Risk in Patients Treated With Placebo in Antidepressant Clinical TrialsArchives of General Psychiatry, 2000
- Once-Daily Venlafaxine Extended Release (XR) Compared With Fluoxetine in Outpatients With Depression and AnxietyThe Journal of Clinical Psychiatry, 1999
- Etrank:a ranking procedure for handling missing data in clinical trials:application to venlafaxine extended-release depression clinical trialJournal of Biopharmaceutical Statistics, 1996
- A multiple imputation strategy for clinical trials with truncation of patient dataStatistics in Medicine, 1995
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Randomization procedures for analyzing clinical trial data with treatment related withdrawalsCommunications in Statistics - Theory and Methods, 1990
- Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivativeBiochemical Pharmacology, 1986
- NIMH Treatment of Depression Collaborative Research ProgramArchives of General Psychiatry, 1985